Macquarie Group LTD Accelerate Diagnostics, Inc Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.54 - $1.41 $4,522 - $11,808
-8,375 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$4.27 - $6.97 $15,342 - $25,043
-3,593 Reduced 30.02%
8,375 $44,000
Q3 2021

Nov 12, 2021
BUY
$5.31 - $8.25 $39,086 - $60,728
7,361 Added 159.78%
11,968 $70,000
Q2 2021

Aug 13, 2021
BUY
$6.81 - $9.23 $31,373 - $42,522
4,607 New
4,607 $37,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $113M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email